3,428
Views
80
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years

Phase II randomized controlled trial in Singapore

, , , , , , , , , & show all
Pages 1259-1271 | Received 02 Apr 2012, Accepted 22 Jun 2012, Published online: 16 Aug 2012

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.